(S1 (S (S (NP (NP (DT The) (NN threshold) (NN level)) (PP (IN of) (NP (NP (JJ adenomatous) (NN polyposis) (NN coli)) (NN protein))) (PP (IN for) (NP (NN mouse) (JJ intestinal) (NN tumorigenesis))))) (. .)))
(S1 (S (S (NP (NP (NP (NP (DT The) (JJ adenomatous) (NN polyposis) (NN coli)) (PRN (-LRB- -LRB-) (NP (NN APC)) (-RRB- -RRB-))) (NN gene)) (, ,) (SBAR (WHNP (WP$ whose) (NNS mutations)) (S (VP (VBP are) (ADJP (JJ responsible) (PP (IN for) (NP (JJ familial) (JJ adenomatous) (NN polyposis))))))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (JJ major) (JJ negative) (NN controller)) (PP (IN of) (NP (DT the) (NN Wnt/beta-catenin) (NN pathway)))))) (. .)))
(S1 (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (JJ dose-dependent) (NNS effects)) (PP (IN of) (NP (NN APC) (NN protein)))) (PP (IN in) (S (VP (VBG suppressing) (NP (JJ intestinal) (NN tumorigenesis)))))))) (, ,) (NP (PRP we)) (VP (VBD constructed) (NP (NP (JJ mutant) (NNS mice)) (VP (VBG carrying) (NP (NP (JJ hypomorphic) (NN Apc) (NNS alleles) (NP (NP (NN Apc-LRB-neoR-RRB-)) (CC and) (NP (NN Apc-LRB-neoF-RRB-)))) (SBAR (WHNP (WP$ whose) (NN expression) (NNS levels)) (S (VP (VBD were) (VP (VBN reduced) (PP (TO to) (NP (NP (NP (CD 20) (NN %)) (CC and) (NP (CD 10) (NN %))) (PP (IN of) (NP (DT the) (JJ wild) (NN type))))) (, ,) (ADVP (RB respectively)))))))))) (. .)))
(S1 (S (S (SBAR (IN Although) (S (NP (DT both) (JJ hypomorphic) (NNS heterozygotes)) (VP (VBD developed) (NP (JJ intestinal) (NNS polyps))))) (, ,) (NP (NN tumor) (NNS multiplicities)) (VP (VBD were) (ADJP (ADJP (RB much) (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (IN in) (NP (NN Apc-LRB-Delta716-RRB-) (NNS mice)))))) (, ,) (NP (NP (NNS heterozygotes)) (PP (IN of) (NP (DT an) (NN Apc) (NN null) (NN allele)))))) (. .)))
(S1 (S (S (PP (IN Like) (PP (IN in) (NP (JJ Apc-LRB-Delta716-RRB-) (NNS mice)))) (, ,) (NP (NP (NN loss)) (PP (IN of) (NP (DT the) (JJ wild-type) (NN Apc) (NN allele)))) (VP (VBD was) (VP (VBN confirmed) (PP (IN for) (NP (NP (DT all) (NNS polyps)) (VP (VBN examined) (PP (IN in) (NP (DT the) (NP (NP (NN Apc-LRB-neoR-RRB-)) (CC and) (NP (NN Apc-LRB-neoF-RRB-))) (NNS mice))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (JJ embryonic) (NN stem) (NNS cells)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT these) (JJ hypomorphic) (NN Apc) (NNS alleles)))))) (, ,) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (NN APC) (NN protein)))) (VP (VBD was) (ADVP (RB inversely)) (VP (VBN correlated) (PP (IN with) (NP (CC both) (NP (DT the) (NN beta-catenin) (NN accumulation)) (CC and) (NP (NN beta-catenin/T-cell) (NN factor) (JJ transcriptional) (NN activity))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (JJ reduced) (NN APC) (NN protein) (NN level)) (VP (VBZ increases) (NP (JJ intestinal) (NN polyp) (NN multiplicity)) (PP (IN through) (NP (NP (JJ quantitative) (NN stimulation)) (PP (IN of) (NP (DT the) (NN beta-catenin/T-cell) (NN factor) (NN transcription)))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBN estimated) (NP (NP (DT the) (NN threshold)) (PP (IN of) (NP (NN APC) (NN protein) (NN level))) (SBAR (WHNP (WDT that)) (S (VP (VBZ forms) (NP (NP (CD one) (NN polyp)) (PP (IN per) (NP (NN mouse)))) (PP (IN as) (NP (NP (QP (RB approximately) (CD 15)) (NN %)) (PP (IN of) (NP (DT the) (JJ wild) (NN type))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (ADVP (RB also)) (VP (VBP suggest) (NP (NP (JJ therapeutic) (NNS implications)) (VP (VBG concerning) (NP (NN Wnt) (NN signaling) (NNS inhibitors)))))) (. .)))
